🇺🇸 Velcade-Dexamethasone in United States
9 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 9
Most-reported reactions
- Hypertension — 2 reports (22.22%)
- Thrombocytopenia — 2 reports (22.22%)
- Blood Urine Present — 1 report (11.11%)
- Haematuria — 1 report (11.11%)
- Haemoglobin Decreased — 1 report (11.11%)
- Infection — 1 report (11.11%)
- Platelet Count Decreased — 1 report (11.11%)
Other Oncology approved in United States
Frequently asked questions
Is Velcade-Dexamethasone approved in United States?
Velcade-Dexamethasone does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Velcade-Dexamethasone in United States?
Intergroupe Francophone du Myelome is the originator. The local marketing authorisation holder may differ — check the official source linked above.